Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Apnimed, a Cambridge, MA-based biopharma company, seeks a Sr. Director of Commercial Planning & Performance who will sharpen the commercial org by owning territory design, call planning, roster management, and data governance.
The role emphasizes AI-driven opportunities and dashboards to keep field decisions accurate as Apnimed prepares for potential AD109 commercialization. The candidate will drive KPI reporting, field engagement measures, and collaboration across departments to ensure
Apnimed is a rapidly growing pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea (OSA) could benefit from treatment with a safe and effective oral medication dosed once daily at bedtime. Our lead development program, AD109, targets the neurologic control of upper airway muscles to maintain an open airway during sleep. Apnimed is committed to innovation, as well as state-of-the-art advancements in sleep medicine, which is leading to the development of a portfolio of novel pharmacologic therapies for sleep apnea and related disorders.
Recognized by the Boston Business Journal as one of the Best Places to Work in both 2024 and 2025, we are continuing to grow and build the foundational operations that enable our employees and our mission to thrive.
Summary:
The Sr. Director, Commercial Planning & Performance reports to the VP, Commercial Operations and is responsible for making Apnimed’s commercial organization sharper and more effective every day, owning territory design, call planning, roster management, customer data, and field engagement measures, and setting the standards for KPI and Field Contact Reporting. The role increasingly uses AI to surface opportunities and anomalies and keep the data behind every field decision clean and current. The successful candidate will also play a key role in anticipating opportunities, market changes, and emerging signals before they show up in a dashboard, partnering closely across the commercial organization to keep commercial execution on track. This is an exciting opportunity to ensure the field never has to wonder whether the numbers reflect their reality as Apnimed prepares for the potential commercialization of AD109, an investigational therapy, and to be at the forefront of a major paradigm shift in the treatment of sleep apnea from medical devices and surgery to a first in class pharmaceutical treatment.
The expected annual base salary range for this role is $270,000.00 to $294,000.00. Final compensation will depend on the selected candidate’s level, education and relevant experience.
Key Job Duties include, but are not limited to: